Similar articles

• Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione).

  BRODIE BB, YU TF, BURNS JJ, CHENKIN T, PATON BC, STEELE JM, GUTMAN AB. BRODIE BB, et al. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):884-7. doi: 10.3181/00379727-86-21263. Proc Soc Exp Biol Med. 1954. PMID: 13204385 No abstract available.
• [On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].

  CONTI L. CONTI L. Farmaco Prat. 1961 May;16:240-3. Farmaco Prat. 1961. PMID: 13695183 Italian. No abstract available.
• [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].

  SCARSELLI V. SCARSELLI V. Farmaco Sci. 1959;14(5):347-51. Farmaco Sci. 1959. PMID: 13663921 Italian. No abstract available.
• Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 2: Chemical transformations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (prenazone) and its main decomposition product N,N'-diphenylhydrazide-2-carboxy-5-methyl-4-hexenoic acid in sulphuric acid concentrated.

  Wachowiak R. Wachowiak R. Arzneimittelforschung. 1979;29(5):725-7. Arzneimittelforschung. 1979. PMID: 582968
• [New antiphlogistic drugs: G-27202].

  TREZZINI C. TREZZINI C. Clin Ter. 1962 Jul 15;23:57-63. Clin Ter. 1962. PMID: 13922446 Italian. No abstract available.